<DOC>
	<DOC>NCT02708732</DOC>
	<brief_summary>This study is a prospective, cross-sectional survey to be administered to real patients in remission from DLBCL using a 15-minute postal or online survey. The project is designed to describe the impact of DLBCL remission on health utility and quality of life. Data collection will occur over a 4-month period.</brief_summary>
	<brief_title>Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma, B-Cell</mesh_term>
	<mesh_term>Lymphoma, Large B-Cell, Diffuse</mesh_term>
	<criteria>Adults greater than or equal to (&gt;/=) 18 years of age Diagnosis of DLBCL and currently in first remission Prior drug treatment for DLBCL Receiving active treatment for DLBCL Relapsed following any treatment for DLBCL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>